耐药性和性饮食疗法 - - 对家庭经验的定性研究
Jennifer H Carroll1, Tracey Parkin1, J Helen Cross2
1School of Health Professions, Faculty of Health, University of Plymouth, Devon, United Kingdom.
Seizure
|May 4, 2024
概括
照顾患有抗药性的孩子是一项挑战. 性饮食疗法 (KDT) 提供了希望,但家庭需要更好的支持,教育和食物选择来成功管理.
科学领域:
- 儿科神经学 儿科神经学
- 饮食疗法 饮食疗法
- 定性研究是指质量研究.
背景情况:
- 的诊断显著影响家庭生活.
- 性饮食疗法 (KDT) 是一种治疗耐药性的选择.
- KDT需要大幅度调整生活方式和饮食.
研究的目的:
- 探索管理和KDT的家庭生活经验.
- 识别KDT遵守中的挑战和促进者.
主要方法:
- 定性描述性研究,涉及21名儿童的父母 (≤18岁) 在KDT.
- 半结构面试进行,转录,并使用诱导主题分析进行分析.
- 参与者通过英国饮中心,慈善机构和社交媒体在国际上招募.
主要成果:
- 出现了四个主要主题:的消耗性,KDT作为新机会的来源,KDT的日常现实,以及为缓解这一过程的未来考虑.
- 家庭报告了积极的结果,并且很高兴试用KDT,无论成功程度如何.
- 强大的支持网络,包括家庭,朋友,慈善机构和KDT团队至关重要.
结论:
- 建议包括改善KDT的获取和向成人服务的过渡.
- 提高教育水平,多种多样的食物选择以及社会支持对家庭至关重要.
- 建议同行指导和改善对KDT服务的访问,以方便家庭管理.
相关概念视频
Arteries of the Lower Limbs
188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
Antiepileptic Drugs: Potassium Channel Activators
176
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
176
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
287
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
287
Electroconvulsive Therapy
37
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
37
Antiepileptic Drugs: Glutamate Antagonists
325
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
325
Antiepileptic Drugs: Sodium Channel Blockers
518
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
518


